Actemra 160mg, a treatment known scientifically as tocilizumab, is a a potent biologic agent primarily utilized for the treatment of rheumatoid arthritis. This effective compound operates by interfering with the activity of interleukin-6 (IL-6), a regulatory protein vital in the inflammatory process. Additionally, Actemra demonstrates effectivenes